In both control and PAH pericytes, CNP attenuated glucose uptake via activation of cyclic GMP-dependent kinase I (cGKI) and subsequent inhibition of the expression of HIF-1α and its target GLUT-1. The gene discussed is PRKG1; the disease is pulmonary arterial hypertension.